June 26, 2018 — MedStar Heart & Vascular Institute physicians participating in a clinical trial have become the first in ...
Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
June 26, 2018
May 18, 2018 — Left atrial appendage closure (LAAC) with the transcatheter Watchman device prevents thromboembolism from ...
May 18, 2018
February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V Left Atrial Appendage (LAA) ...
February 22, 2018
January 18, 2018 – Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc., a worldwide leader ...
January 18, 2018
Dee Dee Wang, M.D., director, structural heart imaging at Henry Ford Hospital, Detroit, explains how her center uses 3-D ...
November 17, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital ...
November 14, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to ...
September 07, 2017
April 25, 2017 — AtriCure Inc. announced it has sold more than 100,000 AtriClip Left Atrial Appendage Exclusion System ...
April 25, 2017
March 29, 2017 — For patients with atrial fibrillation (AFib), closing the area of the heart known as the left atrial ...
March 29, 2017
March 22, 2017 — Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption approval ...
March 22, 2017
March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA) occlusion ...
March 03, 2017
January 6, 2017 — SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial ...
January 06, 2017
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
November 07, 2016
October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compa ...
October 25, 2016
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of financing ...
October 20, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now